We are proud to announce the launch of the Alzheimer’s Trials Data Discovery Challenge — a $75,000 research competition powered by the Alzheimer’s Disease Data Initiative and Vivli, and supported by Alzheimer’s Research UK.
The challenge is built around a fully harmonized control-arm dataset drawn from 11 Alzheimer’s trials across five pharmaceutical sponsors: AstraZeneca, Lilly, Johnson & Johnson, Roche, and Takeda. It brings together 7,089 placebo-arm participants and more than 20 years of data — never before analyzed at this scale.
Three research tracks address questions newly answerable at this scale: sex differences in Alzheimer’s disease, rates of progression, and subtyping and heterogeneity. Up to 24 teams will participate, with $25,000 awarded to the first-place team in each track. Winning teams will also have the opportunity to publish findings in a high-impact journal and present at a major Alzheimer’s conference.
All analysis takes place within Vivli’s secure, cloud-based research environment. Teams must include a PI sponsor and a statistician at minimum.
The first letter of intent deadline is September 1, 2026. Winners will be announced in Spring 2027.